TY - JOUR
T1 - Histamine inhibits lipopolysaccharide-induced tumor necrosis factor-α production in an intercellular adhesion molecule-1- and B7.1-dependent manner
AU - Morichika, Toshihiko
AU - Takahashi, Hideo Kohka
AU - Iwagaki, Hiromi
AU - Yoshino, Tadashi
AU - Tamura, Ryuji
AU - Yokoyama, Minori
AU - Mori, Shuji
AU - Akagi, Tadaatsu
AU - Nishibori, Masahiro
AU - Tanaka, Noriaki
PY - 2003/2/1
Y1 - 2003/2/1
N2 - Lipopolysaccharide (LPS) is recognized as a key molecule in the pathogenesis of Gram negative sepsis and septic shock. In the present study, we demonstrate that LPS (1-1000 pg/ml) concentration dependently up-regulated the expression of intercellular adhesion molecule (ICAM)-1 B7.1, and B7.2 on human monocytes using fluorescence-activated cell sorting analysis, and that tumor necrosis factor (TNF)-α production induced by LPS in peripheral blood mononuclear cells (PBMCs) was inhibited by the addition of antibodies against these adhesion molecules, suggesting the dependence of TNF-α production on cell-cell interaction through these adhesion molecules. Moreover, we found that histamine (10-7-10-4 M) concentration dependently inhibited the expression of ICAM-1 and B7.1, but not B7.2 on monocytes induced by LPS. Histamine also inhibited the responses of TNF-α production induced by LPS. The modulatory effects of histamine on ICAM-1 and B7.1 expression and TNF-α production were all concentration dependently antagonized by famotidine but not by d-chlorpheniramine and thioperamide, and were mimicked by selective H2-receptor agonists but not by H1-, H3-, and H4-receptor agonists, indicating the involvement of H2-receptors in the histamine action. Dibutyryl cAMP down-regulated ICAM-1 and B7.1 expression on monocytes stimulated by LPS, suggesting the mediation by the cyclic adenosine monophosphate-protein kinase A pathway of H2-receptor activation. These results as a whole indicated that histamine via H2-receptor inhibited the LPS-induced TNF-α production through the regulation of ICAM-1 and B7.1 expression, leading to the reduction of innate immune response stimulated by LPS.
AB - Lipopolysaccharide (LPS) is recognized as a key molecule in the pathogenesis of Gram negative sepsis and septic shock. In the present study, we demonstrate that LPS (1-1000 pg/ml) concentration dependently up-regulated the expression of intercellular adhesion molecule (ICAM)-1 B7.1, and B7.2 on human monocytes using fluorescence-activated cell sorting analysis, and that tumor necrosis factor (TNF)-α production induced by LPS in peripheral blood mononuclear cells (PBMCs) was inhibited by the addition of antibodies against these adhesion molecules, suggesting the dependence of TNF-α production on cell-cell interaction through these adhesion molecules. Moreover, we found that histamine (10-7-10-4 M) concentration dependently inhibited the expression of ICAM-1 and B7.1, but not B7.2 on monocytes induced by LPS. Histamine also inhibited the responses of TNF-α production induced by LPS. The modulatory effects of histamine on ICAM-1 and B7.1 expression and TNF-α production were all concentration dependently antagonized by famotidine but not by d-chlorpheniramine and thioperamide, and were mimicked by selective H2-receptor agonists but not by H1-, H3-, and H4-receptor agonists, indicating the involvement of H2-receptors in the histamine action. Dibutyryl cAMP down-regulated ICAM-1 and B7.1 expression on monocytes stimulated by LPS, suggesting the mediation by the cyclic adenosine monophosphate-protein kinase A pathway of H2-receptor activation. These results as a whole indicated that histamine via H2-receptor inhibited the LPS-induced TNF-α production through the regulation of ICAM-1 and B7.1 expression, leading to the reduction of innate immune response stimulated by LPS.
UR - http://www.scopus.com/inward/record.url?scp=0037307987&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037307987&partnerID=8YFLogxK
U2 - 10.1124/jpet.102.042515
DO - 10.1124/jpet.102.042515
M3 - Article
C2 - 12538815
AN - SCOPUS:0037307987
SN - 0022-3565
VL - 304
SP - 624
EP - 633
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 2
ER -